SUVRETTA CAPITAL MANAGEMENT, LLC

CIK 1569064 · EDGAR ↗

sum of disclosed values for 2026-03-31; 0 positions have no disclosed value and are left out of the sum, counted here rather than dropped: $3.9B
every reported holding for this filer and quarter, including ones with no disclosed value: 89
positions with no comparable holding in the prior quarter (kind new), 2026-03-31: 15
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record: 19

Quarter-end snapshot, filed up to 45 days later — not current holdings. What a 13F covers ↓

Changes · Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Position changes into quarter 2026-03-31
The reviewed ticker for the filed issuer name and share class, the same mapping the Reported positions table uses. Symbols are never inferred from names; — means no reviewed mapping.	position matched across quarters by exact reported CUSIP over a registry gap — never a name match	NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE	derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero	reported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated	Prev value	Curr value	Prev shares	Curr shares
—	share class as filed: COM · position key `sid:sec:prov:fa36e00268ee3d6d74f8ff5697fdd99c` · issuer key `cusip6:03969K`	ADD	−$57.0M	+363,000	$347M	$290M	11,964,000	12,327,000
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COMMON STOCK · position key `pos:14234` · issuer key `iss:1897`	NEW	+$263M	+4,168,970	$0	$263M	—	4,168,970
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: TR UNIT · position key `pos:11570` · issuer key `iss:1599` PUT	TRIM	−$318M	−450,000	$546M	$228M	800,000	350,000
—	share class as filed: COM · position key `sid:sec:prov:306a1219dc3e80453ba2cb392e4281b0` · issuer key `cusip6:697947`	ADD	+$50.4M	+261,096	$93.4M	$144M	892,400	1,153,496
—	share class as filed: COM · position key `sid:sec:prov:233302be8852a126d4f3dc726082a4c4` · issuer key `cusip6:03753U`	TRIM	+$37.6M	−620,955	$104M	$142M	4,139,426	3,518,471
—	share class as filed: SPONSORED ADS · position key `sid:sec:prov:235b0febe313b5e3f4a7bc8d76a41721` · issuer key `cusip6:52490G`	ADD	−$6.5M	+972,400	$144M	$137M	6,608,629	7,581,029
—	share class as filed: COM NEW · position key `sid:sec:prov:f5ab5fc62f8ffc42012ac685dc8651c0` · issuer key `cusip6:14070B`	ADD	+$64.6M	+2,032,990	$51.5M	$116M	1,785,610	3,818,600
—	share class as filed: COM · position key `sid:sec:prov:3c51cfeec4a5be695bdb08ebfaa41e00` · issuer key `cusip6:03969F`	TRIM	−$15.0M	−157,865	$124M	$109M	5,188,858	5,030,993
—	share class as filed: COM NEW · position key `sid:sec:prov:dcfd7178444c2349b987cfc50b6bf1d8` · issuer key `cusip6:30233G`	ADD	−$36.1M	+468,690	$143M	$107M	7,827,685	8,296,375
—	share class as filed: COM · position key `sid:sec:prov:1a78f2f31f5e82c1522796ab4aa69fd1` · issuer key `cusip6:04272N`	ADD	+$18.9M	+295,048	$82.6M	$102M	4,106,035	4,401,083
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: SPONSORED ADS · position key `pos:17467` · issuer key `iss:1751`	ADD	+$18.5M	+27,306	$82.5M	$101M	271,401	298,707
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:15642` · issuer key `iss:1334`	ADD	+$1.2M	+43,756	$99.0M	$100M	530,900	574,656
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: CL A · position key `pos:11390` · issuer key `iss:720`	ADD	−$14.5M	+638	$112M	$97.1M	169,069	169,707
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:15818` · issuer key `iss:1742`	ADD	+$2.8M	+75,366	$79.9M	$82.7M	1,083,790	1,159,156
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:14971` · issuer key `iss:1153`	ADD	+$36.0M	+956,730	$43.9M	$79.9M	1,202,070	2,158,800
—	share class as filed: COM · position key `sid:sec:prov:c5f3f37de4d48fd1b29c266e9a76eb0b` · issuer key `cusip6:20454B`	ADD	−$473K	+125,000	$76.2M	$75.7M	14,182,379	14,307,379
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:10715` · issuer key `iss:916`	TRIM	−$10.0M	−19,271	$82.9M	$72.9M	240,861	221,590
—	share class as filed: COM · position key `sid:sec:prov:3224bd4d4c1e7dd823e99e6304f866c2` · issuer key `cusip6:61225M`	ADD	+$16.8M	+866,809	$52.7M	$69.5M	3,360,000	4,226,809
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:13234` · issuer key `iss:230`	TRIM	−$20.3M	−222,385	$83.5M	$63.1M	1,517,630	1,295,245
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:11747` · issuer key `iss:680`	TRIM	+$1.6M	−11,067,037	$53.9M	$55.6M	14,502,004	3,434,967

Flags: no row carries a flag.

1–20 of the 73 changes on this page

Mark-to-market only (no share change) · 35

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
The reviewed ticker for the filed issuer name and share class, the same mapping the Reported positions table uses. Symbols are never inferred from names; — means no reviewed mapping.	position matched across quarters by exact reported CUSIP over a registry gap — never a name match	NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE	derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero	Prev value	Curr value	Prev shares	Curr shares
—	share class as filed: COM NEW · position key `pos:12386` · issuer key `iss:2347`	NO CHANGE	−$32.6M	$156M	$123M	11,548,351	11,548,351
—	share class as filed: SHS · position key `sid:sec:prov:8771e17f16590b5bd511978f2a4f7807` · issuer key `cusip6:N44445`	NO CHANGE	−$7.4M	$117M	$110M	11,190,129	11,190,129
—	share class as filed: COM · position key `pos:10126` · issuer key `iss:2413`	NO CHANGE	+$19.0M	$77.0M	$96.0M	4,768,712	4,768,712
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM NEW · position key `pos:12492` · issuer key `iss:810`	NO CHANGE	−$7.5M	$95.6M	$88.0M	310,262	310,262
—	share class as filed: COM · position key `pos:13686` · issuer key `iss:2049`	NO CHANGE	−$29.1M	$116M	$87.0M	10,286,937	10,286,937
—	share class as filed: COM · position key `sid:sec:prov:44dcd89ab4e3fa904b2bfbfadeb83d25` · issuer key `cusip6:50127T`	NO CHANGE	−$19.4M	$89.1M	$69.7M	8,575,422	8,575,422
—	share class as filed: COM · position key `sid:sec:prov:b66dc0816f9158ee3c706ae6f74ba1a4` · issuer key `cusip6:359616`	NO CHANGE	−$23.9M	$74.2M	$50.3M	6,561,111	6,561,111
—	share class as filed: COM · position key `sid:sec:prov:d00159df48fd34cc806ae902a076ba0a` · issuer key `cusip6:603170`	NO CHANGE	−$14.2M	$55.8M	$41.7M	1,538,662	1,538,662
—	share class as filed: CL A · position key `sid:sec:prov:05537d56ca21ce3a27a9a933baf06b09` · issuer key `cusip6:21217B`	NO CHANGE	+$4.6M	$32.5M	$37.1M	2,841,334	2,841,334
—	share class as filed: COM · position key `sid:sec:prov:d9ef490e51d912cfdcf16dffb423f2d5` · issuer key `cusip6:05153U`	NO CHANGE	+$5.4M	$23.8M	$29.3M	4,372,884	4,372,884
—	share class as filed: SHS CL A · position key `sid:sec:prov:c555142b8f97a692c492343537be9b4c` · issuer key `cusip6:74291D`	NO CHANGE	−$5.6M	$27.6M	$22.1M	12,341,266	12,341,266
—	share class as filed: COM · position key `pos:10682` · issuer key `iss:2314`	NO CHANGE	+$3.8M	$9.0M	$12.8M	3,700,000	3,700,000
—	share class as filed: COM NEW · position key `sid:sec:prov:714d680633cb6e30dfa6e0d524e9cebd` · issuer key `cusip6:00289Y`	NO CHANGE	−$2.1M	$14.1M	$12.0M	2,676,000	2,676,000
—	share class as filed: ADS · position key `sid:sec:prov:43ac1dda87d9c2948d8c04143511cf6d` · issuer key `cusip6:60853G`	NO CHANGE	−$865K	$9.7M	$8.8M	2,221,494	2,221,494
—	share class as filed: COM · position key `sid:sec:prov:bd4b862f6cf27f7bbb6f4d26443faaca` · issuer key `cusip6:52886X`	NO CHANGE	−$5.2M	$12.4M	$7.2M	1,250,000	1,250,000
—	share class as filed: COM · position key `sid:sec:prov:7b1fbafa9cd425ba2536186db2e84dc4` · issuer key `cusip6:N44821`	NO CHANGE	−$917K	$8.0M	$7.1M	7,933,910	7,933,910
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:15125` · issuer key `iss:1798`	NO CHANGE	−$1.2M	$7.8M	$6.6M	13,400	13,400
—	share class as filed: COM NEW · position key `sid:sec:prov:b6b50028a2ad8d2a67e01abc2d70052f` · issuer key `cusip6:49372L`	NO CHANGE	+$810K	$4.5M	$5.3M	716,759	716,759
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:16058` · issuer key `iss:118`	NO CHANGE	−$295K	$4.2M	$3.9M	12,488	12,488
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:17837` · issuer key `iss:1223`	NO CHANGE	−$261K	$2.7M	$2.5M	1,964	1,964
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:13186` · issuer key `iss:1273`	NO CHANGE	−$294K	$2.3M	$2.0M	10,100	10,100
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:15034` · issuer key `iss:573`	NO CHANGE	−$113K	$2.1M	$2.0M	31,680	31,680
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:15220` · issuer key `iss:1725`	NO CHANGE	−$134K	$2.1M	$1.9M	5,860	5,860
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM CL A · position key `pos:15409` · issuer key `iss:1212`	NO CHANGE	+$106K	$1.8M	$1.9M	42,500	42,500
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:17201` · issuer key `iss:1208`	NO CHANGE	+$82.5K	$1.5M	$1.6M	1,830	1,830
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:16411` · issuer key `iss:865`	NO CHANGE	+$20.4K	$1.5M	$1.5M	3,190	3,190
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:16495` · issuer key `iss:1005`	NO CHANGE	−$394K	$1.6M	$1.2M	7,175	7,175
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:11517` · issuer key `iss:1003`	NO CHANGE	−$43.4K	$854K	$811K	10,800	10,800
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:13319` · issuer key `iss:53`	NO CHANGE	−$110K	$679K	$569K	4,990	4,990
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:16392` · issuer key `iss:1549`	NO CHANGE	−$39.2K	$576K	$537K	2,390	2,390
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM SHS · position key `pos:17195` · issuer key `iss:1900`	NO CHANGE	−$62.2K	$546K	$484K	5,475	5,475
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:14114` · issuer key `iss:1624`	NO CHANGE	+$4.3K	$385K	$389K	17,888	17,888
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: SHS USD · position key `pos:13247` · issuer key `iss:2223`	NO CHANGE	−$49.6K	$388K	$338K	1,530	1,530
—	share class as filed: COM · position key `sid:sec:prov:4b145c10f034612809a5ead021971789` · issuer key `cusip6:92790C`	NO CHANGE	−$193K	$520K	$327K	16,700	16,700
a reviewed mapping row for this filed issuer name and share class (never inferred from the name)	share class as filed: COM · position key `pos:12417` · issuer key `iss:2008`	NO CHANGE	+$1.6K	$293K	$295K	3,260	3,260

Flags: no row carries a flag.

Holdings without a security ID are counted, not compared. Method ↗

Reported positions — 2026-03-31

89 positions

View

This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.

Positions SUVRETTA CAPITAL MANAGEMENT, LLC reported for the quarter ended 2026-03-31, as that filer reported them
This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.	a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing	value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0	Shares	Wt
—	ARCUTIS BIOTHERAPEUTICS INC · COM CUSIP 03969K108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$290M	12,327,000	7.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VERADERMICS INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$263M	4,168,970	6.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	STATE STR SPDR S&P 500 ETF T · TR UNIT · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$228M	350,000	5.8%
—	PALVELLA THERAPEUTICS INC NE · COM CUSIP 697947109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$144M	1,153,496	3.7%
—	APELLIS PHARMACEUTICALS INC · COM CUSIP 03753U106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$142M	3,518,471	3.6%
—	LEGEND BIOTECH CORP · SPONSORED ADS CUSIP 52490G102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$137M	7,581,029	3.5%
—	BENITEC BIOPHARMA INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$123M	11,548,351	3.1%
—	CAPRICOR THERAPEUTICS INC · COM NEW CUSIP 14070B309 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$116M	3,818,600	3.0%
—	IMMATICS N.V · SHS CUSIP N44445109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$110M	11,190,129	2.8%
—	ARCUS BIOSCIENCES INC · COM CUSIP 03969F109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$109M	5,030,993	2.8%
—	EYEPOINT INC · COM NEW CUSIP 30233G209 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$107M	8,296,375	2.7%
—	ARRIVENT BIOPHARMA INC · COM CUSIP 04272N102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$102M	4,401,083	2.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	TAIWAN SEMICONDUCTOR MANUFAC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$101M	298,707	2.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	NVIDIA CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$100M	574,656	2.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	META PLATFORMS INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$97.1M	169,707	2.5%
—	KALVISTA PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$96.0M	4,768,712	2.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	GE AEROSPACE · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$88.0M	310,262	2.2%
—	BIOHAVEN LTD · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$87.0M	10,286,937	2.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	SYSCO CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$82.7M	1,159,156	2.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	MGM RESORTS INTERNATIONAL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$79.9M	2,158,800	2.0%
—	COMPASS THERAPEUTICS INC · COM CUSIP 20454B104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$75.7M	14,307,379	1.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	HOME DEPOT INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$72.9M	221,590	1.9%
—	KURA ONCOLOGY INC · COM CUSIP 50127T109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$69.7M	8,575,422	1.8%
—	MONTE ROSA THERAPEUTICS INC · COM CUSIP 61225M102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$69.5M	4,226,809	1.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	BANK AMERICA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$63.1M	1,295,245	1.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ERASCA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$55.6M	3,434,967	1.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CAPITAL ONE FINL CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$55.2M	302,400	1.4%
—	ZURA BIO LTD · CLASS A ORD SHS CUSIP G9TY5A101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$53.9M	9,067,001	1.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	AMAZON COM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$52.9M	254,009	1.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ADVANCED MICRO DEVICES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$52.3M	257,240	1.3%
—	FULCRUM THERAPEUTICS INC · COM CUSIP 359616109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$50.3M	6,561,111	1.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VULCAN MATLS CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$49.4M	181,594	1.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	FERGUSON ENTERPRISES INC · COMMON STOCK NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$49.4M	211,900	1.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	APOLLO GLOBAL MGMT INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$43.2M	387,700	1.1%
—	MINERALYS THERAPEUTICS INC · COM CUSIP 603170101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$41.7M	1,538,662	1.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CRINETICS PHARMACEUTICALS IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$37.9M	1,043,879	1.0%
—	CONTINEUM THERAPEUTICS INC · CL A CUSIP 21217B100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$37.1M	2,841,334	0.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	US FOODS HLDG CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$36.5M	395,970	0.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	PERFORMANCE FOOD GROUP CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$33.1M	386,885	0.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	REPLIMUNE GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$32.3M	4,221,836	0.8%
—	ADVISORSHARES TR · PURE US CANNABIS CUSIP 00768Y453 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$32.1M	9,046,200	0.8%
—	AURA BIOSCIENCES INC · COM CUSIP 05153U107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$29.3M	4,372,884	0.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	UNITEDHEALTH GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$27.2M	100,630	0.7%
—	PROKIDNEY CORP · SHS CL A CUSIP 74291D104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$22.1M	12,341,266	0.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	LIFE TIME GROUP HOLDINGS INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$13.7M	510,349	0.4%
—	WHITEHAWK THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$12.8M	3,700,000	0.3%
—	ABEONA THERAPEUTICS INC · COM NEW CUSIP 00289Y206 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$12.0M	2,676,000	0.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	WINGSTOP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$9.2M	59,500	0.2%
—	MOLECULAR PARTNERS AG · ADS CUSIP 60853G106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$8.8M	2,221,494	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	BOSTON SCIENTIFIC CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$7.8M	123,941	0.2%
—	LEXEO THERAPEUTICS INC · COM CUSIP 52886X107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$7.2M	1,250,000	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	COHERENT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$7.1M	30,000	0.2%
—	INFLARX NV · COM CUSIP N44821101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$7.1M	7,933,910	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	DANAHER CORP DEL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$6.9M	36,380	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ABBOTT LABORATORIES · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$6.9M	66,920	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	THERMO FISHER SCIENTIFIC INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$6.6M	13,400	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	MEDTRONIC PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$6.3M	72,260	0.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	JOHNSON & JOHNSON · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$5.7M	23,400	0.1%
—	KEZAR LIFE SCIENCES INC · COM NEW CUSIP 49372L209 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$5.3M	716,759	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	INTUITIVE SURGICAL INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$5.2M	11,300	0.1%
—	ANTERIS TECHNOLOGIES GLOBAL · COM CUSIP 03675P102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$4.7M	850,000	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	CENCORA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$3.9M	12,488	0.1%
—	SATELLOS BIOSCIENCE INC · COM CUSIP 80401L803 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$2.7M	475,000	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	METTLER TOLEDO INTERNATIONAL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$2.5M	1,964	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	NATERA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$2.0M	10,100	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	DEXCOM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$2.0M	31,680	0.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	STRYKER CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.9M	5,860	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	TESLA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.9M	5,177	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	TALEN ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.9M	5,970	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	MEDLINE INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.9M	42,500	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	MICROSOFT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.8M	4,970	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	MCKESSON CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.6M	1,830	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	HCA HEALTHCARE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.5M	3,190	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	EDWARDS LIFESCIENCES CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.5M	18,700	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	IQVIA HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.2M	7,175	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	WW GRAINGER INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$1.1M	1,000	0.0%
—	SENSEI BIOTHERAPEUTICS INC · COM NEW CUSIP 81728A207 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$1.1M	34,549	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	WATERS CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$960K	3,225	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VISTRA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$902K	6,000	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	IONIS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$811K	10,800	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	AGILENT TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$569K	4,990	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	RESMED INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$537K	2,390	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	SPOTIFY TECHNOLOGY S A · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$533K	1,100	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	VERALTO CORP · COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$484K	5,475	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ROBLOX CORP · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$476K	8,420	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	SAREPTA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$389K	17,888	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	STERIS PLC · SHS USD CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$338K	1,530	0.0%
—	VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗ ticker not yet mapped	$327K	16,700	0.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)	ZIMMER BIOMET HOLDINGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d src ↗	$295K	3,260	0.0%

1–20 of 89 positions

One line per issuer, largest first — open a line for its reported rows. Grouping ↗

Book shape

Tick = median of the 8,748 tracked filers with a 2026-03-31 book (the index median: the 8,662 with a complete book). Concentration uses reported 13F long value, not total assets; the index is withheld when any position lacks a value.

share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 75.4%below median 80.0%
integer Herfindahl–Hirschman index in basis points over disclosed position values: 305 bpsbelow median 446 bps
holdings with no disclosed value (undisclosed, or unreadable on the filing) — kept and counted, never shown as zero: 89 / 89median book 97.5 positions

108 quarter-over-quarter rows

Filing history

Available filing periods
Period	Source
2026-03-31	EDGAR ↗

Complete source filings on SEC EDGAR

The filing on EDGAR is the record, including any filed after this build.

Open SUVRETTA CAPITAL MANAGEMENT, LLC's 13F filings on SEC EDGAR ↗

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings: a position may have changed or closed since the quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars; each record notes its original unit.

Affiliated managers may report the same position, so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice.

Changes · Q1 2026Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Reported positions — 2026-03-31

Book shape

Filing history

Changes · Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.